Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer
Nisha Anand, Sabita K. Murthy, Gudrun Amann et al. · Nature Genetics · 2002
Cited by 255 works. doi:10.1038/ng904
Authors
- Nisha Anand
- Sabita K. Murthy
- Gudrun Amann
- Meredith Wernick
- Lisa Ann Porter
- I. Howard Cukier
- Colin C. Collins
- Joe W. Gray
- Joachim Diebold
- Doug J. Demetrick
- Jonathan M. Lee
References
- Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
- TRANSLATIONAL CONTROL IN MAMMALIAN CELLS
- A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
- Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene
- Positional cloning of ZNF 217 and NABC 1 : Genes amplified at 20q13.2 and overexpressed in breast carcinoma
- Newly Identified Actions of the Vitamin D Endocrine System*
- Identification of an actin-binding protein from Dictyostelium as elongation factor 1a
- Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas
- DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours
- Translation factors as effectors of cell growth and tumorigenesis